Waldenström Macroglobulinemia: 2012 update on diagnosis, risk stratification, and management
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Waldenström Macroglobulinemia: 2012 update on diagnosis, risk stratification, and management
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume 87, Issue 5, Pages 503-510
Publisher
Wiley
Online
2012-04-17
DOI
10.1002/ajh.23192
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Neuropathies of Waldenström's Macroglobulinemia (WM) and IgM-MGUS
- (2014) Christopher J. Klein et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- The Impact of Advanced Age According to IPSSWM Cut-Off on the Outcome of Symptomatic and Asymptomatic Waldenström's Macroglobulinemia at Diagnosis
- (2012) F Ricci et al. Clinical Lymphoma Myeloma & Leukemia
- Autologous Stem Cell Transplantation as a Care Option in Waldenström's Macroglobulinemia
- (2012) Saad Usmani et al. Clinical Lymphoma Myeloma & Leukemia
- Rituximab and Subcutaneous 2-Chloro-2′-Deoxyadenosine as Therapy in Untreated and Relapsed Waldenström's Macroglobulinemia
- (2012) D Laszlo et al. Clinical Lymphoma Myeloma & Leukemia
- Distinctive Clinical and Histological Features of Waldenström's Macroglobulinemia and Splenic Marginal Zone Lymphoma
- (2012) Luca Arcaini et al. Clinical Lymphoma Myeloma & Leukemia
- Bendamustine Therapy in Patients With Relapsed or Refractory Waldenström's Macroglobulinemia
- (2012) Steven P. Treon et al. Clinical Lymphoma Myeloma & Leukemia
- CD138 Expression Helps Distinguishing Waldenström's Macroglobulinemia (WM) From Splenic Marginal Zone Lymphoma (SMZL)
- (2012) Marie-Christine Kyrtsonis et al. Clinical Lymphoma Myeloma & Leukemia
- No significant improvement in the outcome of patients with Waldenström's macroglobulinemia treated over the last 25 years
- (2011) Efstathios Kastritis et al. AMERICAN JOURNAL OF HEMATOLOGY
- Patterns of monoclonal immunoglobulins and serum free light chains are significantly different in black compared to white monoclonal gammopathy of undetermined significance (MGUS) patients
- (2011) Brendan M. Weiss et al. AMERICAN JOURNAL OF HEMATOLOGY
- Long-term follow-up of symptomatic patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia treated with the anti-CD52 monoclonal antibody alemtuzumab
- (2011) S. P. Treon et al. BLOOD
- Stem cell transplant for Waldenström macroglobulinemia: an underutilized technique
- (2011) M A Gertz et al. BONE MARROW TRANSPLANTATION
- Attainment of complete/very good partial response following rituximab-based therapy is an important determinant to progression-free survival, and is impacted by polymorphisms in FCGR3A in Waldenstrom macroglobulinaemia
- (2011) Steven P. Treon et al. BRITISH JOURNAL OF HAEMATOLOGY
- Maintenance Rituximab is associated with improved clinical outcome in rituximab naïve patients with Waldenstrom Macroglobulinaemia who respond to a rituximab-containing regimen
- (2011) Steven P. Treon et al. BRITISH JOURNAL OF HAEMATOLOGY
- Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia
- (2011) Alessandra Tedeschi et al. CANCER
- Temporal and geographic variations of Waldenstrom macroglobulinemia incidence
- (2011) Haijun Wang et al. CANCER
- The Role of Serum Immunoglobulin Free Light Chain in Response and Progression in Waldenstrom Macroglobulinemia
- (2011) X. Leleu et al. CLINICAL CANCER RESEARCH
- Non-random chromosomal deletion clustering at 20q in Waldenström macroglobulinemia
- (2011) Toshihiko Kitahara et al. Hematology
- Long-term response to rituximab and fludarabine combination in IgM anti-myelin-associated glycoprotein neuropathy
- (2011) Berengere Gruson et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia
- (2010) Irene M. Ghobrial et al. AMERICAN JOURNAL OF HEMATOLOGY
- IgM multiple myeloma: Disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia
- (2010) Steven R. Schuster et al. AMERICAN JOURNAL OF HEMATOLOGY
- review: Current status of stem cell mobilization
- (2010) Morie A. Gertz BRITISH JOURNAL OF HAEMATOLOGY
- Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia
- (2010) I. M. Ghobrial et al. CLINICAL CANCER RESEARCH
- Prevalence, clinical aspects, and natural history of IgM MGUS
- (2010) Mary L. McMaster et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Prognostic Factors in Follicular Lymphoma
- (2010) Thomas Relander et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Weekly Bortezomib in Combination With Rituximab in Relapsed or Relapsed and Refractory Waldenström Macroglobulinemia
- (2010) Irene M. Ghobrial et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of the Oral Mammalian Target of Rapamycin Inhibitor Everolimus in Relapsed or Refractory Waldenström Macroglobulinemia
- (2010) Irene M. Ghobrial et al. JOURNAL OF CLINICAL ONCOLOGY
- High-Dose Therapy and Autologous Stem-Cell Transplantation in Waldenström Macroglobulinemia: The Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
- (2010) Charalampia Kyriakou et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy
- (2010) D A Carney et al. LEUKEMIA
- Fludarabine based combinations are highly effective as first-line or salvage treatment in patients with Waldenström macroglobulinemia
- (2010) Stefan Peinert et al. LEUKEMIA & LYMPHOMA
- Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH)
- (2010) Efstathios Kastritis et al. LEUKEMIA RESEARCH
- Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines
- (2010) Stephen M. Ansell et al. MAYO CLINIC PROCEEDINGS
- Novel treatment regimens for Waldenström’s macroglobulinemia
- (2010) Ramón García-Sanz et al. Expert Review of Hematology
- International prognostic scoring system for Waldenstrom macroglobulinemia
- (2009) P. Morel et al. BLOOD
- How I treat Waldenstrom macroglobulinemia
- (2009) S. P. Treon BLOOD
- Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial
- (2009) Morie A. Gertz et al. BRITISH JOURNAL OF HAEMATOLOGY
- Monoclonal gammopathy and neuropathy
- (2009) Sindhu Ramchandren et al. CURRENT OPINION IN NEUROLOGY
- Primary Therapy of Waldenström Macroglobulinemia With Bortezomib, Dexamethasone, and Rituximab: WMCTG Clinical Trial 05-180
- (2009) Steven P. Treon et al. JOURNAL OF CLINICAL ONCOLOGY
- Beyond R-CHOP and the IPI in large-cell lymphoma: Molecular markers as an opportunity for stratification
- (2009) Jason R. Westin et al. Current Hematologic Malignancy Reports
- Thalidomide and rituximab in Waldenstrom macroglobulinemia
- (2008) S. P. Treon et al. BLOOD
- Lenalidomide and Rituximab in Waldenstrom's Macroglobulinemia
- (2008) S. P. Treon et al. CLINICAL CANCER RESEARCH
- Lymphoplasmacytic lymphoma–Waldenstrom's macroglobulinemia
- (2008) Umberto Vitolo et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The International Prognostic Scoring System for Waldenstrom's macroglobulinemia is applicable in patients treated with rituximab-based regimens
- (2008) M. A. Dimopoulos et al. HAEMATOLOGICA
- Increased Incidence of Transformation and Myelodysplasia/Acute Leukemia in Patients With Waldenström Macroglobulinemia Treated With Nucleoside Analogs
- (2008) Xavier Leleu et al. JOURNAL OF CLINICAL ONCOLOGY
- The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG)
- (2008) C Buske et al. LEUKEMIA
- Pathogenesis and progression of monoclonal gammopathy of undetermined significance
- (2008) J Bladé et al. LEUKEMIA
- Serum immunoglobulin free light chain correlates with tumor burden markers in Waldenstrom macroglobulinemia
- (2008) Xavier Leleu et al. LEUKEMIA & LYMPHOMA
- Neurological manifestations of Waldenström macroglobulinemia
- (2008) Joachim M Baehring et al. Nature clinical practice. Neurology
- The incidence and survival of Waldenström's Macroglobulinaemia in South East England
- (2007) K.J. Phekoo et al. LEUKEMIA RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started